← All trials
NCT04177446
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 20, 2019
- Primary completion
- May 31, 2020
- Completion date
- May 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Chinese Academy of Medical SciencesLead sponsor
- Zhengzhou UniversityCollaborator
- Dalian Medical UniversityCollaborator
- Chinese Academy of Medical SciencesReponsible party - principal investigator
- Chinese Academy of Medical SciencesOverall official - principal investigator
- Jiao Tong UniversityCollaborator
- Yabao Pharmaceutical GroupCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.